Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Latest filing published 18 Aug 2022 for Eiger BioPharmaceuticals, Inc., €48k. Read the official filing
Filing timeline
BuySaleDavid Apelian
Insider track record
Disclosed buys
0
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
David Apelian: trading record in brief
All filings by David Apelian on record concern Eiger BioPharmaceuticals, Inc., in the capacity of board member. In total, 2 filings cover trades dated from 11 March 2022 to 16 August 2022.
The open-market record consists of 1 sale worth €48k, with no purchase. Besides market trades, the filings include 1 share grant.
The newest entry dates from 18 August 2022: an open-market sale of €48k, in Eiger BioPharmaceuticals, Inc. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to David Apelian
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
5,000 shares@ US$9.8061100.0% of flowCommon StockSEC:0001567619-22-016461:0
6,000 shares0Common StockSEC:0001140361-22-009254:0
2 of 2 declarations
